Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Progress in retinal and eye research

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.PRETEYERES.2003.08.001PMID 14575722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like Growth Factors

  2024cited by this paper
• Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model

  2005cited by this paper
• 61 THE uPA/uPAR SYSTEM IN CHOROIDAL NEOVASCULARIZATION: A TARGET FOR ANTI-ANGIOGENIC THERAPY.

  2004cited by this paper
• HIF-1: Using Two Hands to Flip the Angiogenic Switch

  2004cited by this paper
• The biology of VEGF and its receptors

  2003cited by this paper
• Role for extracellular signal-responsive kinase-1 and -2 in retinal angiogenesis.

  2003cited by this paper
• ANECORTAVE ACETATE AS MONOTHERAPY FOR THE TREATMENT OF SUBFOVEAL LESIONS IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION (AMD): Interim (Month 6) Analysis of Clinical Safety and Efficacy

  2003cited by this paper
• Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results.

  2003cited by this paper
• Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.

  2003cited by this paper
• Regulation of angiogenesis by hypoxia: role of the HIF system

  2003cited by this paper
• The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target.

  2003cited by this paper
• Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials.

  2003cited by this paper
• Photoreceptor-specific overexpression of platelet-derived growth factor induces proliferation of endothelial cells, pericytes, and glial cells and aberrant vascular development: an ultrastructural and immunocytochemical study.

  2003cited by this paper
• Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization.

  2003cited by this paper
• RhuFab V2 in Wet AMD – 6 Month Continued Improvement Following Multiple Intravitreal Injections

  2003cited by this paper
• Perspectives on diabetic retinopathy.

  2003cited by this paper
• A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

  2003cited by this paper
• Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.

  2003cited by this paper
• Nitric oxide is proangiogenic in the retina and choroid *

  2002cited by this paper
• Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.

  2002cited by this paper
• Safety and Efficacy of Intravitreal Injection of rhuFab VEGF in Combination With Verteporfin PDT on Experimental Choroidal Neovascularization

  2002cited by this paper
• Suppression of diabetic retinopathy with angiopoietin-1.

  2002cited by this paper
• A role for local inflammation in the formation of drusen in the aging eye.

  2002cited by this paper
• Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate.

  2002cited by this paper
• PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION

  2002cited by this paper
• Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy.

  2002cited by this paper
• Somatostatin analogues as drug therapies for retinopathies.

  2002cited by this paper
• Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment.

  2002cited by this paper
• Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

  2002cited by this paper
• Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor.

  2002cited by this paper
• Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.

  2002cited by this paper
• Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

  2002cited by this paper
• Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.

  2002cited by this paper
• Bone marrow–derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis

  2002cited by this paper
• Regulation of matrix metalloproteinase expression by tumor necrosis factor in a murine model of retinal neovascularization.

  2002cited by this paper
• Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.

  2002cited by this paper
• Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization

  2002cited by this paper
• Inhibition of Angiopoietin Signaling Suppresses Retinal Neovascularization

  2002cited by this paper
• AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.

  2002cited by this paper
• Inhibition of retinal neovascularization by intraocular viral-mediated delivery of anti-angiogenic agents.

  2002cited by this paper
• Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II.

  2001cited by this paper
• The role of the plasminogen activation system in angiogenesis and metastasis.

  2001cited by this paper
• Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice.

  2001cited by this paper
• Role of the Matrix Metalloproteinase and Plasminogen Activator-Plasmin Systems in Angiogenesis

  2001cited by this paper
• Systemically Expressed Soluble Tie2 Inhibits Intraocular Neovascularization

  2001cited by this paper
• Recombinant angiostatin prevents retinal neovascularization in a murine proliferative retinopathy model

  2001cited by this paper
• The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.

  2001cited by this paper
• Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

  2001cited by this paper
• Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: Direct correlation with clinical retinopathy of prematurity

  2001cited by this paper
• The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

  2001cited by this paper
• Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells.

  2001cited by this paper
• Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

  2001cited by this paper
• Expression of cytokines and transcription factors in photocoagulated human retinal pigment epithelial cells

  2001cited by this paper
• The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

  2001cited by this paper
• Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.

  2001cited by this paper
• Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).

  2001cited by this paper
• Captopril improves retinal neovascularization via endothelin-1.

  2001cited by this paper
• THE uPA/uPAR SYSTEM IN CHOROIDAL NEOVASCULARIZATION: A TARGET FOR ANTI‐ANGIOGENIC THERAPY.: 61

  2001cited by this paper
• The balance between proteinases and inhibitors in a murine model of proliferative retinopathy.

  2001cited by this paper
• Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor

  2001cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration.

  2000cited by this paper
• A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo

  2000cited by this paper
• Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina

  2000cited by this paper
• Angiopoietin-1 protects the adult vasculature against plasma leakage

  2000cited by this paper
• Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy.

  2000cited by this paper
• The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study.

  2000cited by this paper
• Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions.

  2000cited by this paper
• Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization.

  2000cited by this paper
• VEGF is major stimulator in model of choroidal neovascularization.

  2000cited by this paper
• A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin.

  2000cited by this paper
• Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate

  2000cited by this paper
• Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: implications for capillary-like tube formation in a fibrin matrix.

  2000cited by this paper
• Retinal and choroidal neovascularization

  2000cited by this paper
• Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization

  2000cited by this paper
• Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

  1999cited by this paper
• Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres.

  1999cited by this paper
• Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor.

  1999cited by this paper
• Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

  1999cited by this paper
• Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

  1999cited by this paper
• TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.

  1999cited by this paper
• Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor.

  1999cited by this paper
• Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells*

  1999cited by this paper
• Metabolic acidosis-induced retinopathy in the neonatal rat.

  1999cited by this paper
• Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact.

  1999cited by this paper
• Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes.

  1999cited by this paper
• Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.

  1999cited by this paper
• Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.

  1999cited by this paper
• Basement membrane and growth factor gene expression in normal and diabetic human retinas.

  1999cited by this paper
• Blood vessel maturation: vascular development comes of age.

  1999cited by this paper
• Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression.

  1999cited by this paper
• The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.

  1999cited by this paper
• VASCULAR COMPLICATIONS OF DIABETES MELLITUS

  1999cited by this paper
• Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

  1998cited by this paper
• Matrix metalloproteinases and their inhibitors in human vitreous.

  1998cited by this paper
• Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates.

  1998cited by this paper
• Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby’s fundus dystrophy or retinitis pigmentosa

  1998cited by this paper
• Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531.

  1998cited by this paper
• Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus.

  1998cited by this paper
• The regulation of neovascularization of matrix metalloproteinases and their inhibitors.

  1998cited by this paper

• Normative Database and Determinants of Retinal and Choroidal Vessel Density in Tibetan Children.

  2026cites this paper
• Methamphetamine-Induced Loss of Syndecan-1 and Retinal Endothelial Integrity via the TAAR-1/MMP-9 Pathway

  2025cites this paper
• MicroRNA (miRNA) in the Pathogenesis of Diabetic Retinopathy: A Narrative Review

  2025cites this paper
• Evaluation of the Effect of Acute Elevated Intraocular Pressure on Retinal and Choroidal Microvasculature in Diabetic Rats

  2025cites this paper
• Transfer RNA derived fragment, tRF-Glu-CTC, aggravates the development of neovascular age-related macular degeneration

  2024cites this paper
• Role of mRNA-binding proteins in retinal neovascularization.

  2024cites this paper
• Local delivery of platelet-derived factors mitigates ischemia and preserves ovarian function through angiogenic modulation: A personalized regenerative strategy for fertility preservation.

  2024cites this paper
• Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update

  2024cites this paper
• The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review

  2024cites this paper
• The role of long noncoding RNAs in ocular angiogenesis and vascular oculopathy

  2024cites this paper
• A Novel Optometry-Led Decision-Making Community Referral Refinement Scheme for Neovascular Age-Related Macular Degeneration Screening

  2024cites this paper
• Advanced nanomedicines for the treatment of age-related macular degeneration.

  2024cites this paper
• Understanding the Impact of Polyunsaturated Fatty Acids on Age-Related Macular Degeneration: A Review

  2024cites this paper
• Predicting Diabetic Retinopathy with Machine Learning: Disentangling the Diabetes-Ocular Health Complex

  2024cites this paper
• Unveiling the Therapeutic Potential and Mechanisms of Stanniocalcin-1 in Retinal Degeneration.

  2024cites this paper
• The impact of vitreomacular traction on vitreous vascular endothelial growth factor and placental growth factor levels in neovascular age-related macular degeneration patients

  2024cites this paper
• Posterior eye delivery of angiogenesis-inhibiting RNA nanoparticles via subconjunctival injection.

  2024cites this paper
• Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy

  2024cites this paper
• MicroRNA-376b-3p Suppresses Choroidal Neovascularization by Regulating Glutaminolysis in Endothelial Cells

  2023cites this paper
• HIF-1α Reduction by Lowering Intraocular Pressure Alleviated Retinal Neovascularization

  2023cites this paper
• Finerenone, a Non-Steroidal Mineralocorticoid Receptor Antagonist, Reduces Vascular Injury and Increases Regulatory T-Cells: Studies in Rodents with Diabetic and Neovascular Retinopathy

  2023cites this paper
• CD8+ T Cells Promote Pathological Angiogenesis in Ocular Neovascular Disease

  2023cites this paper
• Deep Learning for Diagnosing and Segmenting Choroidal Neovascularization in OCT Angiography in a Large Real-World Data Set

  2023cites this paper
• Retinal layers changes in patients with age-related macular degeneration treated with intravitreal anti-VEGF agents

  2023cites this paper
• DCZ19931, a novel multi-targeting kinase inhibitor, inhibits ocular neovascularization

  2022cites this paper
• The crosstalk between VEGF signaling pathway and long non-coding RNAs in neovascular retinal diseases: Implications for anti-VEGF therapy

  2022cites this paper
• A Novel “Inside‐Out” Intraocular Nanomedicine Delivery Mode for Nanomaterials’ Biological Effect Enhanced Choroidal Neovascularization Occlusion and Microenvironment Regulation

  2022cites this paper
• tRNA-derived fragment tRF-1001: A novel anti-angiogenic factor in pathological ocular angiogenesis

  2022cites this paper
• Focus on Diabetic Retinopathy (DR) and MicroRNA “What Association”

  2021cites this paper
• Ophthalmological Aspects of von-Hippel–Lindau Syndrome

  2021cites this paper
• NIR-triggered upconversion nanoparticles@thermo-sensitive liposome hybrid theranostic nanoplatform for controlled drug delivery

  2021cites this paper
• Inhibition of hypoxia-inducible factor-1 by salidroside in an in vitro model of choroidal neovascularization

  2021cites this paper
• IL-9 and IL-10 Single-Nucleotide Variants and Serum Levels in Age-Related Macular Degeneration in the Caucasian Population

  2021cites this paper
• The retinal pigment epithelium: Development, injury responses, and regenerative potential in mammalian and non-mammalian systems.

  2021cites this paper
• Lymphocytic Microparticles Suppress Retinal Angiogenesis via Targeting Müller cells in the Ischemic Retinopathy Mouse Model.

  2021cites this paper
• Modulation of p75NTR on Mesenchymal Stem Cells Increases Their Vascular Protection in Retinal Ischemia-Reperfusion Mouse Model

  2021cites this paper
• A small molecular multi-targeting tyrosine kinase inhibitor, anlotinib, inhibits pathological ocular neovascularization.

  2021cites this paper
• Novel Peptide NT/K-CRS Derived from Kringle Structure of Neurotrypsin Inhibits Neovascularization In Vitro and In Vivo

  2021cites this paper
• Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.

  2021cites this paper
• Identification of Dysregulated Pathways and key genes in Human Retinal Angiogenesis using Microarray Metadata

  2020cites this paper
• MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells

  2020cites this paper
• Role of METTL3-Dependent N6-Methyladenosine mRNA Modification in the Promotion of Angiogenesis.

  2020cites this paper
• Extraction, Purification, Characterization, and Antiangiogenic Activity of Acidic Polysaccharide from Buddleja officinalis

  2020cites this paper
• Apolipoprotein(a), an enigmatic anti-angiogenic glycoprotein in human plasma: A curse or cure?

  2020cites this paper
• Suppression of pathological ocular neovascularization by a small molecule, SU1498.

  2020cites this paper
• SHP-2-Induced Activation of c-Myc Is Involved in PDGF-B-Regulated Cell Proliferation and Angiogenesis in RMECs

  2020cites this paper
• Pediatric Neuro-Ophthalmology and OCT

  2020cites this paper
• Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches

  2020cites this paper
• Ribonuclease attenuates retinal ischemia reperfusion injury through inhibition of inflammatory response and apoptosis in mice.

  2020cites this paper
• The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model

  2019cites this paper
• Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism

  2019cites this paper
• Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization

  2019cites this paper
• Effect of MMP-9 gene knockout on retinal vascular form and function.

  2019cites this paper
• Modulating Expression of Thioredoxin Interacting Protein (TXNIP) Prevents Secondary Damage and Preserves Visual Function in a Mouse Model of Ischemia/Reperfusion

  2019cites this paper
• Molecular Mechanisms of Complement System Proteins and Matrix Metalloproteinases in the Pathogenesis of Age-Related Macular Degeneration.

  2019cites this paper
• Wnt Signaling in vascular eye diseases.

  2019cites this paper
• Hypoxia Induced Heparan Sulfate Primes the Extracellular Matrix for Endothelial Cell Recruitment by Facilitating VEGF-Fibronectin Interactions

  2019cites this paper
• Age-related macular degeneration: current knowledge of zinc metalloproteinases involvement.

  2019cites this paper
• RAD51B (rs8017304 and rs2588809), TRIB1 (rs6987702, rs4351379, and rs4351376), COL8A1 (rs13095226), and COL10A1 (rs1064583) Gene Variants with Predisposition to Age-Related Macular Degeneration

  2019cites this paper
• Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future

  2019cites this paper
• Assessment of Global and Local Alterations in Retinal Layer Thickness in Ins2 (Akita) Diabetic Mice by Spectral Domain Optical Coherence Tomography

  2018cites this paper
• Abscisic acid – an anti-angiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages

  2018cites this paper
• Controlled release technology for anti‐angiogenesis treatment of posterior eye diseases: Current status and challenges

  2018cites this paper
• Извадок ANALYSIS OF MATERNAL AND OBSTETRIC RISK FACTORS FOR PREMATURE RETINOPATHY IN PREMATURES WHOSE WEIGHT WAS OVER 1500 G AND GESTATIONAL AGE ABOVE 30 WEEK

  2018cites this paper
• Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy

  2018cites this paper
• Retinopatías neovasculares: etiología y modelos de estudio para la búsqueda de nuevos blancos terapéuticos

  2018cites this paper
• MiR-126 enhances VEGF expression in induced pluripotent stem cell-derived retinal neural stem cells by targeting spred-1.

  2018cites this paper
• Retinal energy demands control vascular supply of the retina in development and disease: The role of neuronal lipid and glucose metabolism

  2017cites this paper
• Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF

  2017cites this paper
• Physical disruption of cell–cell contact induces VEGF expression in RPE cells

  2017cites this paper
• VIP Family Members Prevent Outer Blood Retinal Barrier Damage in a Model of Diabetic Macular Edema

  2017cites this paper
• Biochemical Basis and Therapeutic Implications of Angiogenesis

  2017cites this paper
• Ocular findings in adult subjects with an inactivating mutation in GH releasing hormone receptor gene.

  2017cites this paper
• Microfluidic co-cultures of retinal pigment epithelial cells and vascular endothelial cells to investigate choroidal angiogenesis

  2017cites this paper
• Chemical Proteomics Reveals Soluble Epoxide Hydrolase as a Therapeutic Target for Ocular Neovascularization.

  2017cites this paper
• Angiogenesis-Based Therapies for Eye Diseases

  2017cites this paper
• PACAP and VIP Inhibit HIF‐1α‐Mediated VEGF Expression in a Model of Diabetic Macular Edema

  2017cites this paper
• [Real life visual and anatomic outcomes of aflibercept treatment for treatment-naive patients with exudative age-related macular degeneration].

  2017cites this paper
• 7.34 Retina Reconstruction

  2017cites this paper
• Efficacy and safety of ranibizumab for wet age-related macular degeneration in Chinese patients.

  2017cites this paper
• Ferrochelatase is a therapeutic target for ocular neovascularization

  2017cites this paper
• Targeting VEGF in eye neovascularization: What's new?: A comprehensive review on current therapies and oligonucleotide-based interventions under development.

  2016cites this paper
• Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.

  2016cites this paper
• Neovascular Age-Related Macular Degeneration.

  2016cites this paper
• The molecular mechanism of action of the antiangiogenic natural product, cremastranone

  2016cites this paper
• Abnormal vascular and neural retinal morphology in congenital lifetime isolated growth hormone deficiency.

  2016cites this paper
• Inhibition of RACK1 ameliorates choroidal neovascularization formation in vitro and in vivo.

  2016cites this paper
• Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy

  2016cites this paper
• Ocular neovascular-related diseases: immunological mechanisms of development and the potential of anti-angiogenic therapy

  2016cites this paper
• Aflibercept: a review of its use in the treatment of choroidal neovascularization due to age-related macular degeneration

  2015cites this paper
• Relationship between the complement system, risk factors and prediction models in age-related macular degeneration.

  2015cites this paper
• Study of Multifactorial Eye Disorders in Pakistan

  2015influential citation
• Evidence of a novel gene HERPUD1 in polypoidal choroidal vasculopathy.

  2015cites this paper
• DIFFERENTIAL EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH FACTOR-A ISOFORMS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2015cites this paper
• Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration

  2015influential citation
• The role of retinoic acid related orphan receptor alpha in age-related macular degeneration

  2015cites this paper
• Down-regulation of microRNA-155 attenuates retinal neovascularization via the PI3K/Akt pathway

  2015cites this paper
• Blood, Sweat, and Tears. Angiogenesis, Angiogenesis- Dependent Diseases, and

  2015cites this paper
• Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder.

  2015cites this paper
• Effect of Primary Intravitreal Bevacizumab Injection on Stage 3 Retinopathy of Prematurity with Plus Signs

  2015cites this paper